Skip to main content Scroll Top

Alzheimer

Un nouveau traitement prometteur pour les victimes de commotions cérébrales et d’Alzheimer ?
Photobiomodulation Présentation
Un nouveau traitement prometteur pour les victimes de commotions cérébrales et d’Alzheimer ?
Alzheimer Commotions
26 septembre 2024
Un nouveau traitement prometteur pour les victimes de commotions cérébrales et d’Alzheimer ?
Photobiomodulation : la lumière pour traiter la maladie d’Alzheimer
Alzheimer
Photobiomodulation : la lumière pour traiter la maladie d’Alzheimer
Alzheimer
2 juillet 2024
Photobiomodulation : la lumière pour traiter la maladie d’Alzheimer
Photobiomodulation Therapy: A Novel Therapeutic Approach to Alzheimer’s Disease Made Possible by the Evidence of a Brain-Gut Interconnection
Journal of Integrative Neuroscience
Photobiomodulation Therapy: A Novel Therapeutic Approach to Alzheimer’s Disease Made Possible by the Evidence of a Brain-Gut Interconnection
Alzheimer Articles scientifiques
29 mai 2024
Photobiomodulation Therapy: A Novel Therapeutic Approach to Alzheimer’s Disease Made Possible by the Evidence of a Brain-Gut Interconnection
Translation from Preclinical Research to Clinical Trials: Brain-Gut Photobiomodulation Therapy for Alzheimer’s Disease
Journal of Integrative Neuroscience
Translation from Preclinical Research to Clinical Trials: Brain-Gut Photobiomodulation Therapy for Alzheimer’s Disease
Alzheimer Articles scientifiques
11 mars 2024
Translation from Preclinical Research to Clinical Trials: Brain-Gut Photobiomodulation Therapy for Alzheimer’s Disease
Clinical Trials on Alzheimer’s Disease (CTAD CHINA)
Clinical Trials on Alzheimer’s Disease (CTAD CHINA)
Alzheimer Communications orales
24 octobre 2023
Clinical Trials on Alzheimer’s Disease (CTAD CHINA)
Maladie d’Alzheimer : un essai non médicamenteux innovant démarre à Toulouse
Photobiomodulation Présentation
Maladie d’Alzheimer : un essai non médicamenteux innovant démarre à Toulouse
Alzheimer
25 septembre 2023
Maladie d’Alzheimer : un essai non médicamenteux innovant démarre à Toulouse
Challenges in developing Geroscience trials
Nature Communications Logo
Challenges in developing Geroscience trials
Alzheimer Articles scientifiques
19 août 2023
Challenges in developing Geroscience trials
REGEnLIFE teste la stimulation lumineuse sur les maladies neurodégénératives
PBM visuel
REGEnLIFE teste la stimulation lumineuse sur les maladies neurodégénératives
Alzheimer Commotions
23 mai 2023
REGEnLIFE teste la stimulation lumineuse sur les maladies neurodégénératives
Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation
CTAD 2023
Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation
Alzheimer Communications affichées
1 décembre 2022
Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
JAD Journal of Alzheimer's Disease
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
Alzheimer Articles scientifiques
1 novembre 2022
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
15th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2021, virtual conference
15th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2021, virtual conference
Alzheimer Communications orales
16 septembre 2021
15th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2021, virtual conference
Photobiomodulation at the Level of Single Neural Cells in Culture
Photobiomodulation at the Level of Single Neural Cells in Culture
Alzheimer Communications orales
2 janvier 2021
Photobiomodulation at the Level of Single Neural Cells in Culture
1 2 3 4